ストックスクリーナーアプリを入手
18.68
6.13%
1.0844
前日終値:
$17.60
開ける：
$17.28
24時間の取引高:
512.99K
Relative Volume:
1.59
時価総額：
$755.39M
収益：
-
当期純損益:
$-136.98M
株価収益率:
-4.6479
EPS:
-4.02
ネットキャッシュフロー:
$-126.63M
1週間 パフォーマンス:
-4.99%
1か月 パフォーマンス:
-5.85%
6か月 パフォーマンス:
-12.30%
1年 パフォーマンス:
-40.68%
1日の値動き範囲:
$17.23
$19.93
1週間の範囲:
$17.00
$19.93
52週間の値動き範囲:
$15.47
$36.37
Arrivent Biopharma Inc Stock (AVBP) Company Profile
AVBP を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AVBP
Arrivent Biopharma Inc
|
18.62 | 714.01M | 0 | -136.98M | -126.63M | -4.02 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
629.60 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.82 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
837.92 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.38 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Arrivent Biopharma Inc Stock (AVBP) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-10 | 再開されました | Goldman | Buy |
| 2025-03-20 | 開始されました | B. Riley Securities | Buy |
| 2025-03-10 | 開始されました | Guggenheim | Buy |
| 2024-07-22 | 開始されました | Oppenheimer | Outperform |
| 2024-04-30 | 開始されました | H.C. Wainwright | Buy |
| 2024-02-20 | 開始されました | Citigroup | Buy |
| 2024-02-20 | 開始されました | Goldman | Buy |
| 2024-02-20 | 開始されました | Jefferies | Buy |
すべてを表示
Arrivent Biopharma Inc (AVBP) 最新ニュース
How institutional ownership impacts ArriVent BioPharma Inc. stockMarket Activity Report & Consistent Profit Trading Strategies - newser.com
Why retail investors pile into ArriVent BioPharma Inc. stock2025 Market WrapUp & AI Based Buy and Sell Signals - newser.com
Will ArriVent BioPharma Inc. stock gain from lower inflationJuly 2025 Summary & Daily Price Action Insights - newser.com
Why ArriVent BioPharma Inc. stock could benefit from AI revolution2025 Market Overview & Weekly High Potential Stock Alerts - newser.com
Analyzing ArriVent BioPharma Inc. with risk reward ratio charts2025 Market Trends & Verified Entry Point Signals - newser.com
Evaluating ArriVent BioPharma Inc. with trendline analysisJuly 2025 Momentum & Expert Curated Trade Setup Alerts - newser.com
Why ArriVent BioPharma Inc. stock is favored by pension funds2025 Risk Factors & Expert Approved Trade Ideas - newser.com
How ArriVent BioPharma Inc. stock reacts to Fed rate cuts2025 Retail Activity & Long-Term Growth Stock Strategies - newser.com
Best data tools to analyze ArriVent BioPharma Inc. stock2025 Retail Activity & Low Drawdown Investment Strategies - newser.com
Multi asset correlation models including ArriVent BioPharma Inc.Weekly Stock Summary & Safe Entry Zone Identification - newser.com
Published on: 2025-11-02 12:15:30 - newser.com
Is ArriVent BioPharma Inc. stock a defensive play in 2025Portfolio Risk Summary & Pattern Based Trade Signal System - newser.com
Real time pattern detection on ArriVent BioPharma Inc. stockMarket Sentiment Report & Entry Point Confirmation Alerts - newser.com
Moody Aldrich Partners LLC Takes $1.56 Million Position in ArriVent BioPharma, Inc. $AVBP - MarketBeat
How Bharat Gears Limited Performs During Inflation Historical OverviewCandlestick Pattern Analysis & Rapid Profit Portfolio - earlytimes.in
ArriVent BioPharma’s Phase 3 Study on Firmonertinib: A Potential Game-Changer in NSCLC Treatment - TipRanks
Momentum divergence signals in ArriVent BioPharma Inc. chartBull Run & Daily Risk Controlled Trade Plans - newser.com
What is the fair value of ArriVent BioPharma Inc. stock nowPortfolio Risk Report & Free Technical Pattern Based Buy Signals - newser.com
Is ArriVent BioPharma Inc. meeting your algorithmic filter criteriaPortfolio Performance Report & Real-Time Stock Movement Alerts - newser.com
ArriVent BioPharma, Inc. (NASDAQ:AVBP) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Is ArriVent BioPharma Inc. stock in correction or buying zoneQuarterly Profit Review & Low Drawdown Momentum Trade Ideas - newser.com
Published on: 2025-10-28 03:24:22 - newser.com
Why ArriVent BioPharma Inc. stock remains a top recommendationJuly 2025 Levels & Weekly Breakout Opportunity Watchlist - fcp.pa.gov.br
Arrivent Biopharma Inc (AVBP) 財務データ
収益
当期純利益
現金流量
EPS
1.24%
0.84%
大文字化:
|
ボリューム (24 時間):